Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial

Peer Review reports

Original Submission
30 Nov 2016	Submitted	Original manuscript
7 Dec 2016	Author responded	Author comments - Eva van Doorn
Resubmission - Version 2
7 Dec 2016	Submitted	Manuscript version 2
28 Feb 2017	Reviewed	Reviewer Report - Victor Huber
8 Mar 2017	Reviewed	Reviewer Report - Karl Albert Brokstad
21 Mar 2017	Author responded	Author comments - Eva van Doorn
Resubmission - Version 3
21 Mar 2017	Submitted	Manuscript version 3
Publishing
24 Mar 2017	Editorially accepted
4 Apr 2017	Article published	10.1186/s12879-017-2341-9

Back to article page